Related Experiment Video

Updated: Aug 22, 2025

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.2K

Structural Insight into TNIK Inhibition

Mutsuko Kukimoto-Niino1, Mikako Shirouzu1, Tesshi Yamada2

  • 1Laboratory for Protein Functional and Structural Biology, RIKEN Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.

International Journal of Molecular Sciences
|November 11, 2022
PubMed

Insights

TRAF2- and NCK-interacting kinase (TNIK) is a key target for colorectal cancer therapy. Structural insights into TNIK inhibitors reveal how they block aberrant Wnt/β-catenin signaling, offering new treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • TRAF2- and NCK-interacting kinase (TNIK) is crucial for Wnt/β-catenin signaling in colorectal cancer.
  • Mutations in genes like APC upstream of TNIK often drive aberrant signaling in colorectal cancers.
  • TNIK regulates the β-catenin/T-cell factor 4 transcriptional complex.

Purpose of the Study:

  • To provide structural insights into TNIK inhibitors.
  • To understand the mechanism of inhibition at the ATP-binding site.
  • To explore the impact of various chemical scaffolds on TNIK structure and function.

Main Methods:

  • X-ray crystallography or Cryo-EM to determine inhibitor-bound TNIK structures.
  • Biochemical assays to assess inhibitor potency (e.g., IC50 values).
  • Structure-activity relationship (SAR) analysis of different chemical scaffolds.

Main Results:

  • Detailed structural information of TNIK in complex with nanomolar inhibitors.
  • Identification of key interactions within the ATP-binding site for different inhibitor scaffolds.
  • Demonstration of how inhibitor binding affects TNIK's structural conformation and potentially its function.

Conclusions:

  • TNIK inhibitors targeting the ATP-binding site show promise for colorectal cancer treatment.
  • Structural insights guide the development of more potent and selective TNIK inhibitors.
  • Understanding inhibitor binding mechanisms is essential for therapeutic strategy development.
Keywords:
APCTCF4TNIKWnt signalingcolorectal cancerinhibitorβ-catenin

More Related Videos

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors09:11

Screening for Thermotoga maritima Membrane-Bound Pyrophosphatase Inhibitors

Published on: November 23, 2019

6.7K
Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b10:20

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Published on: November 11, 2016

8.6K

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.0K
Enzymes02:34

Enzymes

Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
82.2K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
54.1K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.8K